Focusing on the role of protein kinase mTOR in endometrial physiology and pathology: insights for therapeutic interventions
- PMID: 38400863
- DOI: 10.1007/s11033-023-08937-w
Focusing on the role of protein kinase mTOR in endometrial physiology and pathology: insights for therapeutic interventions
Abstract
The mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase crucial for cellular differentiation, proliferation, and autophagy. It shows a complex role in the endometrium, influencing both normal and pathogenic conditions. mTOR promotes the growth and maturation of endometrial cells, enhancing endometrial receptivity and decidualization. However, it also contributes to the development of endometriosis (EMs) and endometrial cancer (EC), thus emerging as a therapeutic target for these conditions. In this review, we summarize recent research progress on the mTOR signalling pathway in the endometrium. This provides insights into female endometrial structure and function and guides the prevention and treatment of related diseases.
Keywords: Decidualization; Endometrial cancer; Endometrial receptivity; Endometriosis; Endometrium; mTOR.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
The Role of mTOR and eIF Signaling in Benign Endometrial Diseases.Int J Mol Sci. 2022 Mar 22;23(7):3416. doi: 10.3390/ijms23073416. Int J Mol Sci. 2022. PMID: 35408777 Free PMC article. Review.
-
Extracellular vesicle-packaged PKM2 from endometriotic stromal cells promotes endometrial collagen I deposition by inhibiting autophagy in endometriosis.Cell Signal. 2025 Mar;127:111523. doi: 10.1016/j.cellsig.2024.111523. Epub 2024 Nov 23. Cell Signal. 2025. PMID: 39586523
-
Increased expression of YAP is associated with decreased cell autophagy in the eutopic endometrial stromal cells of endometriosis.Mol Cell Endocrinol. 2019 Jul 1;491:110432. doi: 10.1016/j.mce.2019.04.012. Epub 2019 Apr 20. Mol Cell Endocrinol. 2019. PMID: 31014943
-
Differential induction of autophagy by mTOR is associated with abnormal apoptosis in ovarian endometriotic cysts.Mol Hum Reprod. 2014 Apr;20(4):309-17. doi: 10.1093/molehr/gat091. Epub 2013 Dec 6. Mol Hum Reprod. 2014. PMID: 24319109
-
Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics.Hum Reprod Update. 2016 Apr;22(3):382-403. doi: 10.1093/humupd/dmv060. Epub 2016 Jan 5. Hum Reprod Update. 2016. PMID: 26740585 Review.
Cited by
-
Rapamycin inhibits tamoxifen-induced endometrial proliferation in vitro as a pilot approach for endometrial protection in breast cancer.Sci Rep. 2025 Jan 15;15(1):2112. doi: 10.1038/s41598-025-86586-8. Sci Rep. 2025. PMID: 39819881 Free PMC article.
-
mTOR inhibitors as potential therapeutics for endometriosis: a narrative review.Mol Hum Reprod. 2024 Dec 11;30(12):gaae041. doi: 10.1093/molehr/gaae041. Mol Hum Reprod. 2024. PMID: 39579091 Free PMC article. Review.
-
Endometriosis and autoimmunity.Autoimmun Rev. 2025 Mar 26;24(4):103752. doi: 10.1016/j.autrev.2025.103752. Epub 2025 Jan 17. Autoimmun Rev. 2025. PMID: 39828017 Review.
References
-
- Heitman J, Movva NR, Hall MN (1991) Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253(5022):905–909 - PubMed
-
- Correia B, Sousa MI, Ramalho-Santos J (2020) The mTOR pathway in reproduction: from gonadal function to developmental coordination. Reproduction 159(4):R173–R188 - PubMed
-
- Devis-Jauregui L, Eritja N, Davis ML, Matias-Guiu X, Llobet-Navàs D (2021) Autophagy in the physiological endometrium and cancer. Autophagy 17(5):1077–1095 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous